Dean, Professor, Department of Medicine (Cardiology)
- Cardiology Fellowship, Massachusetts General Hospital, 1987.
- Research Fellowship, Molecular Biology, Harvard Medical School, 1989.
- MD, Stanford Medical School, Palo Alto, CA, 1981.
- MS, Stanford University, Palo Alto, CA, Mathematical Statistics, 1980.
- American Board of Internal Medicine (Cardiovascular Disease).
Representative Recent Publications
- Agarwal M, Agrawal S, Garg L, Garg A, Bhatia N, Kadaria D, Reed GL. (May 2017). Effect of Chronic Obstructive Pulmonary Disease on In-Hospital Mortality and Clinical Outcomes after ST-segment Elevation Myocardial Infarction. Am J Cardiol, 119(10):1555-1559.
- Singh S, Houng A, Wang D, Reed GL. (Mar 2017). Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation. Circulation, 135(11):1011-1020.
- Reed GL, Houng AK, Wang D. Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating alpha2-antiplasmin. Arterioscler Thromb Vasc Biol. 2014;34:2586-2593 (Subject of a featured editorial).
- Tripathi R, Wang D, Sullivan R, Fan T-H, Gladysheva IP and Reed GL. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of ANP/BNP and Heart Failure Development. Hypertension, 2016;67:362-7.
- Gentry MB, Dias JK, Luis A, Patel R, Thornton J, Reed GL. African-American women have a higher risk for developing peripartum cardiomyopathy. Journal of the American College of Cardiology. 2010;55:654-659.
For a complete listing of Dr. Reed's publications, search PubMed.
Venous thromboembolism, ischemic stroke and myocardial infarction, heart failure, monoclonal antibody therapy, vascular disease.
Discovering pathophysiologic mechanisms in thrombosis and heart failure in order to translate those discoveries into new strategies for prevention and treatment.